This Article Full Text Full Text (PDF) All Versions of this Article: 48/5/846    most recent 01.HYP.0000240931.90917.0cv1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ma, J. Articles by Stafford, R. S. Search for Related Content PubMed PubMed Citation Articles by Ma, J. Articles by Stafford, R. S. Pubmed/NCBI databases Medline Plus Health Information High Blood Pressure Related Collections Cardiovascular Pharmacology Related Article

(Hypertension. 2006;48:846.)
© 2006 American Heart Association, Inc.

Original Articles

Changes in Antihypertensive Prescribing During US Outpatient Visits for Uncomplicated Hypertension Between 1993 and 2004

Jun Ma; Ky-Van Lee; Randall S. Stafford

From the Stanford Prevention Research Center, Stanford University School of Medicine, Stanford, Calif.

Correspondence to Randall S. Stafford, Stanford Prevention Research Center, Stanford, CA 94305-5705. E-mail rstafford{at}stanford.edu

Monitoring national patterns of antihypertensive drug therapy is essential to assessing adherence to treatment guidelines and the impact of major scientific publications on physician prescribing. We analyzed data from 2 US National Ambulatory Care Surveys to examine trends between 1993 and 2004 in the prescription of antihypertensive drug classes for uncomplicated hypertension and the association between thiazide and ß-blocker prescribing and physician and patient characteristics. Diuretic prescriptions remained level through 2001 (39%; 95% CI: 34% to 44%) but increased to 53% (48% to 58%) in 2003, largely because of a 72% increase in thiazide prescriptions in the first quarter of 2003 (50%; 95% CI: 40% to 59%). However, these increases did not sustain in 2004. ß-Blocker prescriptions increased modestly from 1993 (24%; 95% CI: 19% to 29%) to 2004 (33%; 95% CI: 28% to 39%). Prescription of calcium channel blockers and angiotensin-converting enzyme inhibitors declined significantly following the sixth Joint National Committee report, but both subsequently rebounded to prereport levels. Prescription of angiotensin II receptor blockers increased continuously from 1% in 1995 to 23% by 2004. Polytherapy prescriptions, particularly those involving 3 drug classes, became increasingly prevalent, accounting for 60% of antihypertensive drug visits by 2004. Prescriptions of thiazides and ß-blockers were both more likely in 1998–2004 (versus 1993–1997). Blacks, women, and hospital outpatients were more likely to receive thiazides. Also, cardiologists were more likely to prescribe ß-blockers. Evidence-based guidelines for antihypertensive drug therapy do impact physician prescribing, but the impact seems to be short lived. Future interventions are imperative for promoting long-term adherence to published guidelines.

Key Words: antihypertensive prescribing • guideline adherence • NAMCS • NHAMCS

Related Article:

Antihypertensive Prescribing: Do We Have Reason to Celebrate?

Barry L. Carter
Hypertension 2006 48: 816-817. [Full Text] [PDF]

This article has been cited by other articles:

				J. Ma and R. S. Stafford Screening, Treatment, and Control of Hypertension in US Private Physician Offices, 2003-2004 Hypertension, May 1, 2008; 51(5): 1275 - 1281. [Abstract] [Full Text] [PDF]

				R. Wexler Target Blood Pressure Level Before Antihypertensive Class to Improve Outcomes More Quickly in Uncomplicated Hypertension Hypertension, March 1, 2007; 49(3): e16 - e16. [Full Text] [PDF]

				B. L. Carter Antihypertensive Prescribing: Do We Have Reason to Celebrate? Hypertension, November 1, 2006; 48(5): 816 - 817. [Full Text] [PDF]